Loading stock data…
$13.03-0.82 (-5.92%)
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.
Integra LifeSciences Holdings Corporation in the Healthcare sector is trading at $13.45 with a market capitalization of $1.4B. Wall Street consensus targets $18.38 (8 analysts), implying a +36.6% move over the next 12 months. The stock is currently 34% below its 52-week high of $20.49, remaining 4.5% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $418.76M↑ | $391.92M↓ | $434.93M↑ | $402.06M↓ | $415.61M |
| Gross Profit | $219.74M↑ | $216.98M↓ | $220.87M↑ | $206.99M↓ | $209.33M |
| Operating Income | $19.29M↑ | $11.47M↓ | $23.04M↑ | $11.76M↑ | -$1.31M |
| Net Income | $4.48M↑ | -$4.62M↓ | -$1.70M↑ | -$5.40M↑ | -$484.07M |
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Sur...